Intellia Therapeutics Inc
SWB:38I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intellia Therapeutics Inc
SWB:38I
|
US |
|
Askoll Eva SpA
F:736
|
IT |
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
OTC:FSPKF
|
NZ |
|
R
|
Rai Way SpA
LSE:0R40
|
IT |
|
B
|
BP PLC
DUS:BPE5
|
UK |
|
A
|
Arch Resources Inc
SWB:ACCA
|
US |
Shareholder Yield
Current shareholder yield for 
38I is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
38I Price
Intellia Therapeutics Inc
| Average Annual Return | -40.49% |
| Standard Deviation of Annual Returns | 28.65% |
| Max Drawdown | -96% |
| Market Capitalization | 2.4B EUR |
| Shares Outstanding | 297 300 301 |
| Percentage of Shares Shorted |
N/A
|
